Drug Products Industry Research

Find market research and analysis on the drug products industry. Our industry research reports give you a comprehensive look into market conditions and forecasts, in addition to product trends and analyses. Industry overviews, market share and growth, sales statistics and projections, and company profiles are also featured.

	Title	Published	Price
1	Snapshots US Pharmaceuticals 2009	Nov 2009	$600.00
	Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and more... Published by: Snapdata International Group | Search inside this report
2	Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis	Nov 2009	$175.00
	Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. more... Published by: Aruvian's R'search | Search inside this report
3	Pharmaceutical Industry in Mexico	Nov 2009	$275.00
	Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease. Mexico’s pharmaceutical policy environment is in a period of more... Published by: Aruvian's R'search | Search inside this report
4	Pharmaceuticals Industry Report	Nov 2009	$1,500.00
	The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial more... Published by: Plimsoll Publishing Ltd.
5	Antipsychotics Market Forecast	Oct 2009	$15,200.00
	Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is more... Published by: Datamonitor
6	Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes	Oct 2009	$5,700.00
	Introduction Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest more... Published by: Datamonitor
7	Prescription Drug Wholesaling in the US - Industry Risk Rating Report	Oct 2009	$825.00
	Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Prescription Drug Wholesaling in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of more... Published by: IBISWorld | Search inside this report
8	Antidepressants Market Forecast	Oct 2009	$15,200.00
	Introduction With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial more... Published by: Datamonitor
9	Snapshots Bulgaria Pharmaceuticals 2009	Oct 2009	$600.00
	Snapdata's Snapshots Bulgaria Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Bulgarian pharmaceutical market and more... Published by: Snapdata International Group | Search inside this report
10	Snapshots Australia Pharmaceuticals 2009	Oct 2009	$600.00
	Snapdata's Snapshots Australia Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Australian pharmaceutical market and more... Published by: Snapdata International Group | Search inside this report
12	Snapshots France Pharmaceuticals 2009	Oct 2009	$600.00
	Snapdata's Snapshots France Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the French pharmaceutical market and more... Published by: Snapdata International Group | Search inside this report
13	Global Pharmaceuticals Industry Report	Oct 2009	$1,500.00
	The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of more... Published by: Plimsoll Publishing Ltd.
14	Anticonvulsants Market Forecast	Oct 2009	$15,200.00
	Introduction In 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase more... Published by: Datamonitor
15	Antidiabetics Market Forecast	Oct 2009	$15,200.00
	Introduction Datamonitor expects the antidiabetics market to reach $38 billion, across the seven major markets, by 2018. The growth will be driven by the launch of new drug classes, notably the DPP-IV inhibitors and GLP-1 agonists, more... Published by: Datamonitor
16	Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential	Oct 2009	$15,200.00
	Introduction In 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase more... Published by: Datamonitor
17	Top 20 Cancer Therapy Brands Forecast	Oct 2009	$15,200.00
	Introduction The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven major more... Published by: Datamonitor
18	Top 20 Japanese Companies & Their Pipelines 2009	Oct 2009	$225.00
	In spite of the global economic downturn, Japanese pharmaceutical companies are realizing growth by capitalizing on M&A opportunities, predominantly through acquisition of specialty and generic pharmaceutical companies based in the United States and Asia-Pacific region. more... Published by: Canon Communications, LLC
19	China Hospital Drug Utilization Volume Executive Summary 2nd Edition 2009	Oct 2009	$4,400.00
	The total Chinese pharmaceutical market had reached RMB 828.36 billion (US$ 120.84 billion, at an exchange rate of US $1 = RMB 6.83) with an annual growth rate (AGR) of 26.50% in 2008. The growth more... Published by: Draco Healthcare Consulting LLC
20	The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets	Oct 2009	$3,995.00
	At their most basic level, wellness programs represent an attempt to encourage good health and thereby decrease utilization of health care products and services. They have evolved out of necessity from the current U.S. more... Published by: Kalorama Information
21	The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)	Oct 2009	$3,500.00
	The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness more... Published by: Kalorama Information
22	Cough, Cold and Allergy (hay Fever) Remedies in Venezuela	Oct 2009	$900.00
	Euromonitor International's Cough, Cold and Allergy Products in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), more... Published by: Euromonitor International | Search inside this report
23	The Pharmaceutical Market: Australia	Sep 2009	$1,130.00
	Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section more... Published by: Espicom Healthcare Intelligence | Search inside this report
24	KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED-Company Report	Sep 2009	$750.00
	Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and more... Published by: Life Science Analytics (LSA) | Search inside this report
25	The Outlook for Pharmaceuticals in South East Asia	Sep 2009	$3,790.00
	The eight Asian countries covered in this service represented a total market of 588 million people and a combined GDP of US$2.8 trillion in 2008 Business opportunities in Asian pharmaceutical markets are very different more... Published by: Espicom Healthcare Intelligence
	Title	Published	Price